News and Media

UPM PHARMACEUTICALS®, INC. INITIATES DOCUMENTUM COMPLIANCE MANAGER

Baltimore, MD, February 10, 2009 - As part of continued efforts to provide clients with quality and responsive service, UPM Pharmaceuticals®, Inc. is pleased to announce the initiation of an Electronic Document Management System (EDMS): Documentum Compliance Manager (DCM).

DCM will assist UPM Pharmaceuticals®, Inc. in sharing documents with clients electronically in compliance with FDA 21 CFR Part 11 and internal policies, while continuing to meet product and service quality standards. The EDMS manages and tracks electronic documents through the document’s lifecycles including creation, approval, distribution, new version replacement, and
retirement. Audit trails and signatures are maintained to comply with applicable regulations.

“Documentum is a state of the art, Part 11 compliant electronic document management system which will provide increased document control capabilities, and improved turnaround on documents critical to our clients’ needs,” states Ted McCarthy, Executive Director, Quality Assurance.

UPM Pharmaceuticals®, Inc. is a Baltimore-based contract development and manufacturing organization providing customized formulation development, manufacturing, and analytical services to pharmaceutical, biotechnology, academic, and veterinary clients.

Fully appreciating that time-to-market is critical, UPM offers remarkably flexible, affordable, and rapid outsourcing services designed to meet clients’ specific development and manufacturing needs. Their clients represent both small and large companies, within the pharmaceutical and biotechnology industries, and academic institutions who have a focus on clinical studies.

Contact:
Frank Sorce
973-765-0131 (office)
sorce@upm-inc.com
UPM Pharmaceuticals®, Inc.
6200 Seaforth Street, Baltimore, MD 21224
Phone: 410.843.3738
Fax: 410.633.4438